Cas no 51679-57-3 (1-Bromo-4-(difluoromethyl)sulfonylbenzene)
1-Bromo-4-(difluoromethyl)sulfonylbenzene Chemical and Physical Properties
Names and Identifiers
-
- 1-bromo-4-(difluoromethylsulfonyl)benzene
- EN300-8160302
- AKOS005362469
- 1-bromo-4-((difluoromethyl)sulfonyl)benzene
- 4-[(Difluoromethyl)sulphonyl]bromobenzene
- NS-04352
- 1-bromo-3-((difluoromethyl)sulfonyl)benzene
- 4-[(Difluoromethyl)sulfonyl]bromobenzene
- 4-(Difluoromethylsulfonyl)bromobenzene
- 1-bromo-4-(difluoromethane)sulfonylbenzene
- MFCD13188442
- SCHEMBL6729425
- 51679-57-3
- 1-Bromo-4-[(difluoromethyl)sulfonyl]benzene
- D76799
- 1-BROMO-4-DIFLUOROMETHANESULFONYLBENZENE
- CS-0108469
- DA-05287
- 893-087-7
- TQU0221
- 1-Bromo-4-(difluoromethyl)sulfonylbenzene
-
- MDL: MFCD13188442
- Inchi: 1S/C7H5BrF2O2S/c8-5-1-3-6(4-2-5)13(11,12)7(9)10/h1-4,7H
- InChI Key: LILXEWHLJBFHDS-UHFFFAOYSA-N
- SMILES: BrC1C=CC(=CC=1)S(C(F)F)(=O)=O
Computed Properties
- Exact Mass: 269.91617Da
- Monoisotopic Mass: 269.91617Da
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 13
- Rotatable Bond Count: 2
- Complexity: 252
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.8
- Topological Polar Surface Area: 42.5?2
1-Bromo-4-(difluoromethyl)sulfonylbenzene Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | B802015-2.5mg |
1-Bromo-4-[(difluoromethyl)sulfonyl]benzene |
51679-57-3 | 2.5mg |
$ 50.00 | 2022-06-06 | ||
| TRC | B802015-5mg |
1-Bromo-4-[(difluoromethyl)sulfonyl]benzene |
51679-57-3 | 5mg |
$ 70.00 | 2022-06-06 | ||
| TRC | B802015-25mg |
1-Bromo-4-[(difluoromethyl)sulfonyl]benzene |
51679-57-3 | 25mg |
$ 230.00 | 2022-06-06 | ||
| Apollo Scientific | PC48638-250mg |
4-[(Difluoromethyl)sulphonyl]bromobenzene |
51679-57-3 | 250mg |
£126.00 | 2025-02-21 | ||
| Apollo Scientific | PC48638-1g |
4-[(Difluoromethyl)sulphonyl]bromobenzene |
51679-57-3 | 1g |
£263.00 | 2025-02-21 | ||
| abcr | AB275186-250 mg |
4-(Difluoromethylsulfonyl)bromobenzene, 95%; . |
51679-57-3 | 95% | 250 mg |
€244.60 | 2023-07-20 | |
| abcr | AB275186-1 g |
4-(Difluoromethylsulfonyl)bromobenzene, 95%; . |
51679-57-3 | 95% | 1 g |
€469.50 | 2023-07-20 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1179109-1g |
1-Bromo-4-((difluoromethyl)sulfonyl)benzene |
51679-57-3 | 97% | 1g |
¥7349.00 | 2024-05-10 | |
| Key Organics Ltd | NS-04352-1MG |
1-bromo-4-difluoromethanesulfonylbenzene |
51679-57-3 | >95% | 1mg |
£37.00 | 2025-02-09 | |
| Key Organics Ltd | NS-04352-5MG |
1-bromo-4-difluoromethanesulfonylbenzene |
51679-57-3 | >95% | 5mg |
£46.00 | 2025-02-09 |
1-Bromo-4-(difluoromethyl)sulfonylbenzene Related Literature
-
Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
-
Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
-
J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
-
Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
-
Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
Additional information on 1-Bromo-4-(difluoromethyl)sulfonylbenzene
Introduction to 1-Bromo-4-(difluoromethyl)sulfonylbenzene (CAS No. 51679-57-3)
1-Bromo-4-(difluoromethyl)sulfonylbenzene, identified by the Chemical Abstracts Service Number (CAS No.) 51679-57-3, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound belongs to the class of aryl sulfones, characterized by a sulfur atom double-bonded to two oxygen atoms and attached to an aromatic ring. The presence of both bromine and difluoromethyl substituents on the benzene ring enhances its reactivity and utility in synthetic chemistry, making it a valuable intermediate in the development of novel bioactive molecules.
The structural features of 1-Bromo-4-(difluoromethyl)sulfonylbenzene make it a versatile building block for medicinal chemists. The bromine atom at the ortho position relative to the sulfonyl group provides a handle for further functionalization via cross-coupling reactions, such as Suzuki or Buchwald-Hartwig couplings, which are widely employed in constructing complex molecular architectures. Additionally, the electron-withdrawing nature of the sulfonyl group and the electron-donating effect of the difluoromethyl group create a unique electronic environment on the aromatic ring, influencing its interaction with biological targets.
In recent years, there has been growing interest in aryl sulfones due to their demonstrated pharmacological properties. These compounds have shown promise as inhibitors of various enzymes and receptors involved in inflammatory pathways, cancer metabolism, and infectious diseases. The specific substitution pattern of 1-Bromo-4-(difluoromethyl)sulfonylbenzene positions it as a key precursor for synthesizing derivatives with enhanced binding affinity and selectivity. For instance, modifications at the positions adjacent to the sulfonyl group can lead to compounds with improved solubility, metabolic stability, and target engagement.
One of the most compelling applications of 1-Bromo-4-(difluoromethyl)sulfonylbenzene is in the development of kinase inhibitors. Kinases are critical enzymes that regulate many cellular processes, and their dysregulation is implicated in numerous diseases, particularly cancer. By incorporating this compound into drug candidates, researchers can exploit its ability to modulate kinase activity through precise structural tuning. The difluoromethyl group, in particular, has been shown to enhance binding interactions by increasing lipophilicity and reducing hydrogen bonding potential, thereby improving drug-like properties.
Recent advances in computational chemistry have further accelerated the discovery process using 1-Bromo-4-(difluoromethyl)sulfonylbenzene as a scaffold. Molecular modeling studies have revealed that subtle changes in the substituent arrangement can significantly alter enzyme binding kinetics. This has enabled medicinal chemists to design libraries of analogs with optimized pharmacokinetic profiles. Furthermore, high-throughput screening (HTS) techniques combined with structure-based drug design have identified lead compounds derived from this intermediate that exhibit potent activity against target proteins.
The agrochemical sector also benefits from the versatility of 1-Bromo-4-(difluoromethyl)sulfonylbenzene. Sulfonylurea herbicides, a class of compounds known for their high efficacy at low application rates, often rely on similar aromatic scaffolds for their activity. By functionalizing this core structure, researchers can develop new herbicides with improved environmental profiles and crop safety. The bromine substituent allows for further derivatization into thiols or amines, which can be incorporated into more complex heterocyclic systems designed to disrupt plant-specific metabolic pathways.
From a synthetic chemistry perspective, 1-Bromo-4-(difluoromethyl)sulfonylbenzene serves as an excellent starting material for exploring new reaction methodologies. Transition-metal-catalyzed reactions have been particularly fruitful in transforming this compound into diverse libraries of heterocycles and polycyclic structures. For example, palladium-catalyzed C-H activation strategies have enabled direct functionalization at unactivated carbon centers adjacent to the sulfonyl group, expanding synthetic possibilities beyond traditional coupling reactions.
The safety and handling of 1-Bromo-4-(difluoromethyl)sulfonylbenzene are paramount considerations in industrial and academic settings. While not classified as hazardous under standard conditions, appropriate personal protective equipment (PPE) should be used when handling this compound due to its potential reactivity with strong nucleophiles or bases. Storage should be conducted in a cool, dry environment away from incompatible materials to prevent degradation or unintended reactions.
In conclusion,1-Bromo-4-(difluoromethyl)sulfonylbenzene (CAS No. 51679-57-3) represents a critical intermediate with broad applications across pharmaceuticals and agrochemicals. Its unique structural features enable diverse synthetic transformations and biological activities, making it indispensable for modern drug discovery efforts. As research continues to uncover new therapeutic targets and synthetic strategies,1-Bromo-4-(difluoromethyl)sulfonylbenzene will undoubtedly remain at the forefront of molecular innovation.
51679-57-3 (1-Bromo-4-(difluoromethyl)sulfonylbenzene) Related Products
- 20808-12-2(Fluoromethyl Phenyl Sulfone)
- 57830-58-7(Benzene, 1,3,5-tris[(trifluoromethyl)sulfonyl]-)
- 63647-61-0(Benzene, 1-[(difluoromethyl)sulfonyl]-2-[(trifluoromethyl)thio]-)
- 1535-65-5(Difluoromethyl Phenyl Sulfone)
- 312-20-9(1-Bromo-4-(trifluoromethyl)sulfonylbenzene)
- 1150271-31-0(2,6-Dibromo-4-(trifluoromethylsulfonyl)toluene)
- 426-58-4(trifluoromethanesulfonylbenzene)
- 16368-43-7(2-Bromo-4-((trifluoromethyl)sulfonyl)aniline)
- 63572-14-5(Benzene, 1-(phenylthio)-3,5-bis[(trifluoromethyl)sulfonyl]-)
- 1133116-35-4(2-Bromo-1-methyl-4-(trifluoromethylsulfonyl)benzene)